154 related articles for article (PubMed ID: 32223987)
1. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years.
Bennetsen AKK; Baandrup L; Aalborg GL; Kjaer SK
Gynecol Oncol; 2020 Jun; 157(3):693-699. PubMed ID: 32223987
[TBL] [Abstract][Full Text] [Related]
2. The association of reproductive factors with risk of non-epithelial ovarian cancer and comparison with serous ovarian cancer.
Hemmingsen CH; Kjaer SK; Bennetsen AKK; Dehlendorff C; Baandrup L
Gynecol Oncol; 2021 Aug; 162(2):469-474. PubMed ID: 34016454
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
4. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.
Trétarre B; Molinié F; Woronoff AS; Bossard N; Bessaoud F; Marrer E; Grosclaude P; Guizard AV; Delafosse P; Bara S; Velten M; Lapôtre-Ledoux B; Ligier K; Léone N; Arveux P; Uhry Z
Gynecol Oncol; 2015 Nov; 139(2):324-9. PubMed ID: 26383829
[TBL] [Abstract][Full Text] [Related]
6. Ovarian and tubal cancer in Denmark: an update on incidence and survival.
Gottschau M; Mellemkjaer L; Hannibal CG; Kjaer SK
Acta Obstet Gynecol Scand; 2016 Oct; 95(10):1181-9. PubMed ID: 27454324
[TBL] [Abstract][Full Text] [Related]
7. Patterns and progress in ovarian cancer over 14 years.
Chan JK; Cheung MK; Husain A; Teng NN; West D; Whittemore AS; Berek JS; Osann K
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):521-8. PubMed ID: 16946210
[TBL] [Abstract][Full Text] [Related]
8. Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.
Hannibal CG; Cortes R; Engholm G; Kjaer SK
Acta Obstet Gynecol Scand; 2008; 87(12):1353-60. PubMed ID: 18951210
[TBL] [Abstract][Full Text] [Related]
9. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989-2015.
van der Hel OL; Timmermans M; van Altena AM; Kruitwagen RFPM; Slangen BFM; Sonke GS; van de Vijver KK; van der Aa MA
Eur J Cancer; 2019 Sep; 118():97-104. PubMed ID: 31326731
[TBL] [Abstract][Full Text] [Related]
10. Trends in the incidence and mortality of ovarian cancer in Denmark 1978-2002. Comparison with other Nordic countries.
Kjaerbye-Thygesen A; Huusom LD; Frederiksen K; Kjaer SK
Acta Obstet Gynecol Scand; 2005 Oct; 84(10):1006-12. PubMed ID: 16167920
[TBL] [Abstract][Full Text] [Related]
11. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
12. Trends in survival of epithelial ovarian/tubal cancer by histology and socioeconomic status in Denmark 1996-2017.
Faber MT; Horsbøl TA; Baandrup L; Dalton SO; Kjaer SK
Gynecol Oncol; 2022 Jan; 164(1):98-104. PubMed ID: 34763941
[TBL] [Abstract][Full Text] [Related]
13. Childhood and adolescent ovarian malignant tumors in Israel. A nationwide study.
Menczer J; Sadetzki S; Murad H; Barda G; Andreev H; Barchana M
Acta Obstet Gynecol Scand; 1999 Oct; 78(9):813-7. PubMed ID: 10535348
[TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer incidence and survival by histologic type in Osaka, Japan.
Ioka A; Tsukuma H; Ajiki W; Oshima A
Cancer Sci; 2003 Mar; 94(3):292-6. PubMed ID: 12824924
[TBL] [Abstract][Full Text] [Related]
15. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer incidence in the United States, 1992-1999.
Quirk JT; Natarajan N
Gynecol Oncol; 2005 May; 97(2):519-23. PubMed ID: 15863154
[TBL] [Abstract][Full Text] [Related]
17. Survival of ovarian cancer patients in Denmark: Results from the Danish gynaecological cancer group (DGCG) database, 1995-2012.
Edwards HM; Noer MC; Sperling CD; Nguyen-Nielsen M; Lundvall L; Christensen IJ; Høgdall C
Acta Oncol; 2016 Jun; 55 Suppl 2():36-43. PubMed ID: 27355258
[TBL] [Abstract][Full Text] [Related]
18. Trends in rectal cancer incidence, relative survival, and mortality in Denmark during 1978-2018.
Urbute A; Sand FL; Belmonte F; Iversen LH; Munk C; Kjaer SK
Eur J Cancer Prev; 2022 Sep; 31(5):451-458. PubMed ID: 34723868
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
20. Epidemiologic pathology of ovarian cancer from the Vaud Cancer Registry, Switzerland.
Levi F; Franceschi S; La Vecchia C; Ruzicka J; Gloor E; Randimbison L
Ann Oncol; 1993 Apr; 4(4):289-94. PubMed ID: 8518218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
